I don’t believe Epichem can produce GMP tablets which is what would be needed in a human trial. I recall in one of the Q&A discussions, Colin stated they potentially could make MPL for a dog trial but not humans.
Also, the quarterly states the COVID human trial is scheduled to commence AFTER the initial pharmacokinetics from the FightMND trial.
@adreamer talked about why they would be planning the trials in this order in his post this morning.
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-419
-
- There are more pages in this discussion • 314 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $20.93K | 102.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36959 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 71032 | 2 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |